|
schneckenbecken dysplasia
|
DOID_0050775 |
|
|
rapadilino syndrome
|
DOID_0050774 |
|
|
non-syndromic X-linked intellectual disability
|
DOID_0050776 |
|
|
non-syndromic intellectual disability
|
DOID_0050889 |
|
|
50 percent cytotoxicity
|
BAO_0000588 |
|
|
cells per microliter
|
UO_0000316 |
|
|
cells per well
|
UO_0000317 |
|
|
lipid kinase inhibitor
|
CHEBI_50916 |
|
|
assay medium
|
BAO_0000596 |
|
|
fixative
|
CHEBI_50913 |
|
|
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
|
CHEBI_50914 |
|
|
antiemetic
|
CHEBI_50919 |
|
|
protein-RNA interaction assay
|
BAO_0000593 |
|
|
protein-DNA interaction assay
|
BAO_0000591 |
|
|
DNA-RNA interaction assay
|
BAO_0000590 |
|
|
venom
|
CHEBI_78505 |
|
|
ARC syndrome
|
DOID_0050763 |
|
|
choreaacanthocytosis
|
DOID_0050766 |
|
|
neuroacanthocytosis
|
DOID_0050765 |
|
|
H1-receptor antagonist
|
CHEBI_37955 |
|
